CPG10101

DRUG2 trials

Sponsors

Pfizer

Conditions

Hepatitis, Chronic Active

Phase 1

CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Relapsed Hepatitis C Virus (HCV) Subjects

CompletedNCT00142103

PfizerHepatitis, Chronic Active

Start: 2005-09-30End: 2007-02-28Updated: 2011-05-16

Phase 2

CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder (Null And Partial Responder) Hepatitis C Virus (HCV) Genotype 1 Infected Subjects

CompletedNCT00277238

PfizerHepatitis, Chronic Active

Start: 2006-02-28End: 2007-07-31Updated: 2017-03-08